Target Name: MIR4435-2HG
NCBI ID: G541471
Other Name(s): MIR4435-2 host gene, transcript variant 1 | MORRBID | lncRNA-AWPPH | LINC00978 | AGD2 | MIR4435-2HG variant 1 | MIR4435-2 host gene | MIR4435-1HG

MIR4435-2HG: A Potential Drug Target and Biomarker

Mir4435-2HG, a protein encoded by the human gene MIR4435-2, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function make it an attractive target for drug development, as it can modulate the activity of multiple cellular pathways, including cell signaling pathways, cell adhesion, and cellular processes that are relevant to many diseases.

The MIR4435-2 gene is located on chromosome 6p21.3 and encodes a protein of approximately 21 kDa. The protein has four known functions:

1. Facilitating the formation of tight junctions in epithelial cells: MIR4435-2 has been shown to regulate the formation of tight junctions in epithelial cells, which are responsible for maintaining tissue structure and barriers. By modulating the activity of various genes involved in cell signaling pathways, MIR4435-2 has been shown to play a role in the development and maintenance of epithelial tissue structure.
2. Involved in the development and progression of cancer: MIR4435-2 has been shown to be involved in the development and progression of cancer. Its expression has been observed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, MIR4435-2 has been shown to promote the growth and survival of cancer cells, making it a potential drug target for cancer treatment.
3. Regulating cell adhesion and migration: MIR4435-2 has been shown to regulate cell adhesion and migration, which are important processes involved in the development and progression of cancer. By modulating the activity of genes involved in cell signaling pathways, MIR4435-2 has been shown to play a role in the development and progression of cancer.
4. Involved in the regulation of inflammation: MIR4435-2 has been shown to be involved in the regulation of inflammation. Its expression has been observed in various types of inflammation, including neurodegenerative diseases and autoimmune disorders. Additionally, MIR4435-2 has been shown to promote the production of pro-inflammatory cytokines, potentially contributing to the development and progression of these diseases.

Despite its potential as a drug target and biomarker, MIR4435-2 has not yet been fully characterized, and more research is needed to understand its function and the potential implications for disease. However, its unique structure and function make it an attractive target for drug development, and further studies are needed to determine its potential as a drug and biomarker.

Protein Name: MIR4435-2 Host Gene

More Common Targets

MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2